JEFFREY SO: Open Payments
NPI 1659600799 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,968 in 105 payments from 22 companies in 2025. Trend: 2023 $1,649 · 2024 $2,873 · 2025 $2,968
Food & beverage: $2,862Education: $100Travel & lodging: $6
| Company | Payments | Amount |
|---|---|---|
| Organogenesis Inc. | 27 | $519 |
| E.R. Squibb & Sons, L.L.C. | 12 | $453 |
| UCB, Inc. | 20 | $374 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $274 |
| Galderma Laboratories, L.P. | 4 | $180 |
| Janssen Biotech, Inc. | 6 | $180 |
| Botanix SB Inc | 2 | $158 |
| Lilly USA, LLC | 3 | $155 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $106 |
Products named: Sotyktu, CYGNUS DUAL, Bimzelx, Winlevi, TREMFYA, SOFDRA, NEMLUVIO, EBGLYSS.
Industry payments across CA — which companies pay providers there.
